7-132133091-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_020911.2(PLXNA4):āc.5547A>Gā(p.Ala1849Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,614,040 control chromosomes in the GnomAD database, including 11,483 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.093 ( 961 hom., cov: 32)
Exomes š: 0.11 ( 10522 hom. )
Consequence
PLXNA4
NM_020911.2 synonymous
NM_020911.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.95
Genes affected
PLXNA4 (HGNC:9102): (plexin A4) Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including axon guidance; positive regulation of axonogenesis; and regulation of GTPase activity. Predicted to act upstream of or within several processes, including nervous system development; regulation of axon extension involved in axon guidance; and regulation of negative chemotaxis. Predicted to be located in plasma membrane. Predicted to be part of semaphorin receptor complex. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 7-132133091-T-C is Benign according to our data. Variant chr7-132133091-T-C is described in ClinVar as [Benign]. Clinvar id is 3059020.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-3.95 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXNA4 | NM_020911.2 | c.5547A>G | p.Ala1849Ala | synonymous_variant | 31/32 | ENST00000321063.9 | NP_065962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXNA4 | ENST00000321063.9 | c.5547A>G | p.Ala1849Ala | synonymous_variant | 31/32 | 5 | NM_020911.2 | ENSP00000323194.4 | ||
PLXNA4 | ENST00000359827.7 | c.5547A>G | p.Ala1849Ala | synonymous_variant | 31/32 | 5 | ENSP00000352882.3 |
Frequencies
GnomAD3 genomes AF: 0.0933 AC: 14194AN: 152078Hom.: 952 Cov.: 32
GnomAD3 genomes
AF:
AC:
14194
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.131 AC: 32707AN: 249408Hom.: 3035 AF XY: 0.131 AC XY: 17728AN XY: 135270
GnomAD3 exomes
AF:
AC:
32707
AN:
249408
Hom.:
AF XY:
AC XY:
17728
AN XY:
135270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.109 AC: 158886AN: 1461844Hom.: 10522 Cov.: 31 AF XY: 0.111 AC XY: 81059AN XY: 727218
GnomAD4 exome
AF:
AC:
158886
AN:
1461844
Hom.:
Cov.:
31
AF XY:
AC XY:
81059
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0933 AC: 14206AN: 152196Hom.: 961 Cov.: 32 AF XY: 0.0961 AC XY: 7153AN XY: 74422
GnomAD4 genome
AF:
AC:
14206
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
7153
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
707
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PLXNA4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at